Literature DB >> 19341710

Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process.

Mari M Sato1, Masayuki Nashimoto, Takenobu Katagiri, Yasutaka Yawaka, Masato Tamura.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that are emerging as important post-transcriptional gene regulators. miR-206 is unique in that it is expressed only in skeletal muscle, including the myoblastic C2C12 cell line. In C2C12 cells, miR-206 expression was reduced dramatically after bone morphogenetic protein (BMP)-2 treatment. The down-regulation of miR-206 expression was also observed after co-transfection with constitutively-active Smad1 and Smad4, which are the intracellular signaling molecules of the BMP pathway. BMP-2 also reduced miR-206 expression in the presence of alpha-amanitin in a similar manner to that in the absence of alpha-amanitin. Moreover, the expression of pri-miR-206 was increased upon BMP-2 treatment for 6h compared to that in the absence of BMP-2. These results suggested that BMP-2 down-regulates miR-206 expression at the post-transcriptional level, by inhibiting the processing of pri-miR-206 into mature miR-206, and that BMP-2 could regulate miRNA biogenesis by a novel mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341710     DOI: 10.1016/j.bbrc.2009.03.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  miR-30 family members negatively regulate osteoblast differentiation.

Authors:  Tingting Wu; Haibo Zhou; Yongfeng Hong; Jing Li; Xinquan Jiang; Hui Huang
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

3.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

Review 4.  Smad-mediated regulation of microRNA biosynthesis.

Authors:  Matthew T Blahna; Akiko Hata
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

5.  A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle.

Authors:  Kelsi Radzikinas; Linh Aven; Zhihua Jiang; Thanh Tran; Jesus Paez-Cortez; Karthik Boppidi; Jining Lu; Alan Fine; Xingbin Ai
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

6.  Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins.

Authors:  Junya Nojima; Kazuhiro Kanomata; Yumi Takada; Toru Fukuda; Shoichiro Kokabu; Satoshi Ohte; Takatora Takada; Tohru Tsukui; Takamasa S Yamamoto; Hiroki Sasanuma; Katsumi Yoneyama; Naoto Ueno; Yasushi Okazaki; Ryutaro Kamijo; Tetsuya Yoda; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

7.  miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop.

Authors:  Kristina Kapinas; Catherine Kessler; Tinisha Ricks; Gloria Gronowicz; Anne M Delany
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

Review 8.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability.

Authors:  Beatriz Gámez; Edgardo Rodríguez-Carballo; Ramon Bartrons; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

10.  Expression of microRNA-30c and its target genes in human osteoblastic cells by nano-bioglass ceramic-treatment.

Authors:  A Moorthi; S Vimalraj; C Avani; Zhiming He; Nicola C Partridge; N Selvamurugan
Journal:  Int J Biol Macromol       Date:  2013-03-01       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.